These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Antitussive effects of mu- and kappa-agonists in diabetic rats. Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y. Neurosci Lett; 1993 May 14; 154(1-2):65-8. PubMed ID: 8395669 [Abstract] [Full Text] [Related]
13. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. Suarez-Roca H, Maixner W. J Pharmacol Exp Ther; 1993 Feb 14; 264(2):648-53. PubMed ID: 7679733 [Abstract] [Full Text] [Related]
18. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone. Gistrak MA, Paul D, Hahn EF, Pasternak GW. J Pharmacol Exp Ther; 1989 Nov 14; 251(2):469-76. PubMed ID: 2553921 [Abstract] [Full Text] [Related]
19. U-50,488, a selective kappa opioid agonist: comparison to other reputed kappa agonists. Von Voigtlander PF, Lewis RA. Prog Neuropsychopharmacol Biol Psychiatry; 1982 Nov 14; 6(4-6):467-70. PubMed ID: 6298890 [Abstract] [Full Text] [Related]
20. The site of anti-arthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Wilson JL, Nayanar V, Walker JS. Br J Pharmacol; 1996 Aug 14; 118(7):1754-60. PubMed ID: 8842441 [Abstract] [Full Text] [Related] Page: [Next] [New Search]